Skip to main content
Log in

Unfavourable pregnancy outcomes after vedolizumab during pregnancy

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Bell C, et al. Systematic Review and Meta-Analysis: Safety of Vedolizumab During Pregnancy in Patients with Inflammatory Bowel Disease. Journal of Gastroenterology and Hepatology : 10 Jun 2021. Available from: URL: http://doi.org/10.1111/jgh.15574

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Unfavourable pregnancy outcomes after vedolizumab during pregnancy. Reactions Weekly 1861, 13 (2021). https://doi.org/10.1007/s40278-021-97813-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-97813-0

Navigation